-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Nodding is a granuloma disease that usually affects lung function, although the effect on the heart is also common.
, however, the risks of these outcomes and the characteristics of predicting them remain largely unknown.
recently, a research paper published in JAHA, an authoritative journal in the field of cardiovascular disease, aims to explore the epidemiological characteristics of heart failure, room conduction block, and roomal titration in patients with or without nodule disease.
researchers used a database of outpatient surgery, emergency or inpatients at the California Office of Health Planning and Development between 2005 and 2015 to identify residents over the age of 21.
researchers identified the risk of nodule disease for heart failure, room conduction block, and roomic titration, and linked it to the Social Security Death Index to determine overall mortality.
of 225,279,964 California residents, the researchers found 19,762 (0.09 percent) people with nod disease.
of all risk factors, nodule disease is heart failure (risk ratio of 11.2; 95% CI is 10.7-11.7), room conduction block (HR is 117.7) 95% CI is 103.3-134.0) and roomary titration (HR is 26.1; 95% CI is 24.2-28.1) the strongest predictive factors.
any form of heart injury can predict outcomes.
about 22 percent (95 percent CI is 18-26 percent) of the association between nomad disease and increased mortality can be explained by at least one cardiovascular outcome.
, it can be seen that nodule disease, as a predictor of heart failure, room conduction block and room titration, is more risk-related than all known risk factors.
it is necessary to monitor and predict these outcomes in patients with nodule disease, and the diagnosis of nodule disease should be carefully considered for patients with heart failure, room conduction block or roomic titration.